Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Vitamin D Deficiency 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Subcutaneous panniculitis-like T-cell lymphoma 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Musculoskeletal Diseases 1Multiple Sclerosis, Relapsing-Remitting 1Lymphoma, T-Cell 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Leukemia, B-Cell 1Leukemia 1Immunoblastic Lymphadenopathy 1Hematologic Diseases 1Enteropathy-Associated T-Cell Lymphoma 1Anemia, Aplastic 1

Interventions

pembrolizumab 6Paclitaxel 4Cyclophosphamide 4Psychiatric Rehabilitation 3Flow Cytometry 3Filgrastim 3Drug Therapy 3Carboplatin 3valspodar 2trametinib 2sargramostim 2epacadostat 2dabrafenib 2X-Rays 2Specimen Handling 2Nivolumab 2Microarray Analysis 2Methylprednisolone 2Melphalan 2Injections 2Immunologic Techniques 2Gemcitabine 2Dexamethasone 2Dasatinib 2Biopsy 2Azacitidine 2Analgesia 2Amifostine 2Alemtuzumab 2vocimagene amiretrorepvec 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Cholecalciferol × Lymphoid × Clear all
NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡